Related Experiment Video
Updated: Aug 8, 2026

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
How I approach a thrombotic thrombocytopenia purpura patient
1Department of Pathology and Laboratory Medicine, University of North Carolina Hospitals, Chapel Hill, North Carolina 27514, USA. brecher@med.unc.edu
In the past few years, advances in the understanding of the pathophysiology of thrombotic thrombocytopenic purpura (TTP) has made great strides; however, this has yet to significantly impact the clinical care of patients. Although the use of daily plasma exchange is evidence-based and well established, many of the facets of clinical care remain largely empiric. Our laboratory has had a sustained interest in studying and optimizing the use of plasma exchange in TTP patients. This article presents a summary of how our clinical service approaches TTP patients and manages commonly occurring problems.
In the past few years, advances in the understanding of the pathophysiology of thrombotic thrombocytopenic purpura (TTP) has made great strides; however, this has yet to significantly impact the clinical care of patients. Although the use of daily plasma exchange is evidence-based and well established, many of the facets of clinical care remain largely empiric. Our laboratory has had a sustained interest in studying and optimizing the use of plasma exchange in TTP patients. This article presents a summary of how our clinical service approaches TTP patients and manages commonly occurring problems.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease III: Interprofessional Care

